Pacer Advisors Portfolio holdings
AUM
$39.6B
1-Year Return
5.04%
This Quarter Return
+10.34%
1 Year Return
+5.04%
3 Year Return
+42.86%
5 Year Return
+91.64%
10 Year Return
+332.32%
AUM
$5.32B
AUM Growth
+$623M
(+13%)
Cap. Flow
+$354M
Cap. Flow
% of AUM
6.65%
Top 10 Holdings %
Top 10 Hldgs %
31.02%
Holding
1,573
New
308
Increased
332
Reduced
859
Closed
60
Top Buys
| 1 |
Equinix
EQIX
|
$41.9M |
| 2 |
American Tower
AMT
|
$33.5M |
| 3 |
CD
Chindata Group Holdings Limited American Depositary Shares
CD
|
$28M |
| 4 |
Crown Castle
CCI
|
$20.9M |
| 5 |
CONE
CyrusOne Inc Common Stock
CONE
|
$13.7M |
Top Sells
| 1 |
Apple
AAPL
|
$89.3M |
| 2 |
Microsoft
MSFT
|
$66.1M |
| 3 |
Amazon
AMZN
|
$63.1M |
| 4 |
Meta Platforms (Facebook)
META
|
$26.3M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
$25.2M |
Sector Composition
| 1 | Real Estate | 18.33% |
| 2 | Technology | 16.47% |
| 3 | Consumer Discretionary | 8.8% |
| 4 | Healthcare | 7.69% |
| 5 | Communication Services | 7.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PSXP
1251
DELISTED
PHILLIPS 66 PARTNERS LP
PSXP
| $74K | ﹤0.01% |
2,800
-250
| -8% | -$6.61K |
|
1252
MacroGenics
MGNX
$113M
| $73K | ﹤0.01% |
3,185
+2,072
| +186% | +$47.5K |
|
1253
Xencor
XNCR
$593M
| $73K | ﹤0.01% |
1,682
-458
| -21% | -$19.9K |
|
|
GTHX
1254
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $73K | ﹤0.01% |
4,076
+2,766
| +211% | +$49.5K |
|
|
IMGN
1255
DELISTED
Immunogen Inc
IMGN
| $73K | ﹤0.01% |
11,286
+148
| +1% | +$957 |
|
|
DRNA
1256
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $70K | ﹤0.01% |
3,184
+148
| +5% | +$3.25K |
|
1257
Alector
ALEC
$282M
| $69K | ﹤0.01% |
4,554
+2,726
| +149% | +$41.3K |
|
1258
Telus
TU
$25.1B
| $69K | ﹤0.01% |
+3,488
| New | +$69K |
|
|
NS
1259
DELISTED
NuStar Energy L.P.
NS
| $68K | ﹤0.01% |
4,703
-505
| -10% | -$7.3K |
|
1260
Globant
GLOB
$2.68B
| $67K | ﹤0.01% |
+307
| New | +$67K |
|
|
TBIO
1261
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $67K | ﹤0.01% |
3,640
+1,876
| +106% | +$34.5K |
|
|
CNST
1262
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $67K | ﹤0.01% |
2,312
+592
| +34% | +$17.2K |
|
1263
Celldex Therapeutics
CLDX
$1.56B
| $64K | ﹤0.01% |
+3,656
| New | +$64K |
|
1264
Relay Therapeutics
RLAY
$684M
| $64K | ﹤0.01% |
+1,549
| New | +$64K |
|
|
SHLX
1265
DELISTED
Shell Midstream Partners, L.P.
SHLX
| $61K | ﹤0.01% |
6,043
-402
| -6% | -$4.06K |
|
1266
Atara Biotherapeutics
ATRA
$84.3M
| $60K | ﹤0.01% |
122
-37
| -23% | -$18.2K |
|
|
EPZM
1267
DELISTED
Epizyme, Inc
EPZM
| $60K | ﹤0.01% |
5,508
+1,409
| +34% | +$15.3K |
|
1268
Adverum Biotechnologies
ADVM
$70.9M
| $58K | ﹤0.01% |
535
+154
| +40% | +$16.7K |
|
|
KDMN
1269
DELISTED
Kadmon Holdings, Inc.
KDMN
| $58K | ﹤0.01% |
13,961
+5,813
| +71% | +$24.2K |
|
1270
Myriad Genetics
MYGN
$627M
| $57K | ﹤0.01% |
2,906
-2,936
| -50% | -$57.6K |
|
1271
Syndax Pharmaceuticals
SNDX
$1.41B
| $56K | ﹤0.01% |
+2,536
| New | +$56K |
|
1272
Tootsie Roll Industries
TR
$3B
| $55K | ﹤0.01% |
2,153
-2,477
| -53% | -$63.3K |
|
1273
Arcturus Therapeutics
ARCT
$475M
| $54K | ﹤0.01% |
+1,246
| New | +$54K |
|
1274
Rocket Pharmaceuticals
RCKT
$349M
| $54K | ﹤0.01% |
983
-650
| -40% | -$35.7K |
|
1275
Arcus Biosciences
RCUS
$1.19B
| $54K | ﹤0.01% |
2,079
+338
| +19% | +$8.78K |
|